Therapy News and Research

RSS

EU conducts research into mechanisms and effects of atrial fibrillation

Atrial fibrillation is the most common type of irregular heartbeat, or cardiac arrhythmia, affecting 2-3 % of the European population and as many as one in 10 people over the age of 80.

27 Sep 2018

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Adolescent and young adult patients with acute lymphoblastic leukemia were significantly more likely to relapse than pediatric ALL patients, and factors including lower clinical trial enrollment and shorter duration of therapy were associated with relapse.

27 Sep 2018

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.

27 Sep 2018

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

A defective gene causes thick, sticky mucus to build up in the lungs of patients with cystic fibrosis. There, it traps bacteria, causing patients to develop frequent lung infections that progressively damage these vital organs and impair patients' ability to breathe.

27 Sep 2018

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis -- a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions -- researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.

27 Sep 2018

Olfactory cells could act as 'Trojan horse,' delivering anticancer therapy to dangerous brain tumors

A special type of cell essential to the ability of olfactory neurons to regenerate may be genetically engineered to deliver anticancer therapy to the dangerous brain tumors called glioblastomas.

27 Sep 2018

Hope for paraplegics in the horizon

According to a new study from the University of Louisville, four paraplegics have found hope. Paraplegia is complete paralysis of the lower limbs due to damage or injury to the spinal cord. The team of researchers have published their success story in a study in the latest issue of the New England Journal of Medicine.

26 Sep 2018

Researchers take first steps in developing 'paintable' chemotherapy for melanoma

Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases.

26 Sep 2018

Urine liquid biopsies could help monitor response to immunotherapy in bladder cancer patients

Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumor environment, according to research published today (Wednesday) in the Journal of Experimental Medicine.

26 Sep 2018

Medrisk provides telerehabilitation for injured workers in hurricane affected areas

Hurricane Florence set records for rainfall from a hurricane in both North and South Carolina. Flooding has rendered many roads impassable and more flooding is expected. The hurricane caused approximately $44 billion in property damage and lost output according to Moody's Analytics, and repairs and cleanup will take months.

26 Sep 2018

How Sensors are Changing the Way We Deliver Physiotherapy

An interview with Sandrine Ortega from SWORD Health, at the NHS Health and Care Innovation Expo, discussing the greatest barriers to physiotherapy in the UK, and how SWORD Phoenix is improving patient outcomes for musculoskeletal disorders.

From SWORD Health 26 Sep 2018

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make informed decisions on how to sequence treatments for patients with epidermal growth factor receptor mutation-positive (EGFR M+) non-small cell lung cancer (NSCLC).

26 Sep 2018

Who is Your Possible Self?

An interview with My Possible Self, discussing how it is helping patients with mental health conditions who are waiting for NHS counseling.

From My Possible Self Limited 26 Sep 2018

Researchers to explore sex differences in cardiovascular and renal physiology

A person's sex can be a defining factor in how well--or how poorly--they respond to disease, therapy and recovery. Experts at the forefront of sex-specific research will convene next week at the sixth APS conference on sex differences in cardiovascular and renal physiology.

26 Sep 2018

Researchers review current state and future potential of biologic medications to treat asthma in children

Researchers have performed a comprehensive review of the current state and future potential of using biologic medications to treat asthma in children.

26 Sep 2018

Cancer Research UK, Keystone Symposia collaborate for cancer-related research

Keystone Symposia and Cancer Research UK are pleased to announce their new collaboration consisting of a series of annual cancer-related scientific research conferences organized by Keystone Symposia in collaboration with Cancer Research UK.

26 Sep 2018

Digital CBT can improve insomnia symptoms, daytime functioning and overall health

Treating insomnia with digital programs can improve insomnia symptoms, daytime functioning and overall health, a new study from the University of Oxford and Northwestern Medicine has found.

26 Sep 2018

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.

26 Sep 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.

26 Sep 2018

Therapy News and Research

EU conducts research into mechanisms and effects of atrial fibrillation

Lower clinical trial enrollment associated with relapse risk in AYA leukemia patients

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Antibiotic resistance in cystic fibrosis linked to decreased microbial diversity and pulmonary function

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

Olfactory cells could act as 'Trojan horse,' delivering anticancer therapy to dangerous brain tumors

Hope for paraplegics in the horizon

Researchers take first steps in developing 'paintable' chemotherapy for melanoma

Urine liquid biopsies could help monitor response to immunotherapy in bladder cancer patients

Medrisk provides telerehabilitation for injured workers in hurricane affected areas

How Sensors are Changing the Way We Deliver Physiotherapy

Survey: Physicians need more information to assess impact of NSCLC treatment sequencing

Who is Your Possible Self?

Researchers to explore sex differences in cardiovascular and renal physiology

Researchers review current state and future potential of biologic medications to treat asthma in children

Cancer Research UK, Keystone Symposia collaborate for cancer-related research

Digital CBT can improve insomnia symptoms, daytime functioning and overall health

Mesoblast’s MPC therapy for children featured at symposium for congenital heart disease

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News